No matter how cynical the overall market is Agios Pharmaceuticals Inc (AGIO) performance over the last week is recorded 3.26%

On Friday, Agios Pharmaceuticals Inc (NASDAQ: AGIO) was 6.34% up from the session before settling in for the closing price of $36.61. A 52-week range for AGIO has been $23.42 – $62.58.

When this article was written, the company’s average yearly earnings per share was at -163.69%. With a float of $54.91 million, this company’s outstanding shares have now reached $58.04 million.

Agios Pharmaceuticals Inc (AGIO) Insider Updates

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agios Pharmaceuticals Inc stocks. The insider ownership of Agios Pharmaceuticals Inc is 5.50%, while institutional ownership is 108.12%. The most recent insider transaction that took place on Sep 26 ’25, was worth 134,247. Before that another transaction happened on Sep 05 ’25, when Company’s Principal Accounting Officer sold 8,546 for $36.87, making the entire transaction worth $315,091. This insider now owns 868 shares in total.

Agios Pharmaceuticals Inc (AGIO) Performance Highlights and Predictions

Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.47 earnings per share (EPS) during the time that was less than consensus figure (set at 7.91) by -9.38. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.99 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around -163.69% per share during the next fiscal year.

Agios Pharmaceuticals Inc (NASDAQ: AGIO) Trading Performance Indicators

You can see what Agios Pharmaceuticals Inc (AGIO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 14.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 55.33.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.05, a number that is poised to hit -1.90 in the next quarter and is forecasted to reach -7.36 in one year’s time.

Technical Analysis of Agios Pharmaceuticals Inc (AGIO)

Let’s dig in a bit further. During the last 5-days, its volume was 0.53 million. That was inferior than the volume of 0.72 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 55.59%.

During the past 100 days, Agios Pharmaceuticals Inc’s (AGIO) raw stochastic average was set at 81.25%, which indicates a significant decrease from 92.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.34 in the past 14 days, which was lower than the 1.56 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $37.48, while its 200-day Moving Average is $34.05. However, in the short run, Agios Pharmaceuticals Inc’s stock first resistance to watch stands at $40.00. Second resistance stands at $41.06. The third major resistance level sits at $42.87. If the price goes on to break the first support level at $37.13, it is likely to go to the next support level at $35.32. Assuming the price breaks the second support level, the third support level stands at $34.26.

Agios Pharmaceuticals Inc (NASDAQ: AGIO) Key Stats

There are 58,102K outstanding shares of the company, which has a market capitalization of 2.26 billion. As of now, sales total 36,500 K while income totals 673,730 K. Its latest quarter income was 12,460 K while its last quarter net income were -112,020 K.